PRODUCTS
PRODUCTS
APIs and intermediates
PRODUCTS
Ceftaroline fosamil Intermediates
PRODUCTS
Crisaborole API & Intermedia…
Topiroxostat API & Intermedi…
Tavaborole API & Intermedia…
Upadacitinib API & Intermed…
BrexpiprazoleAPI & Intermedi…
TEST
Others
Ticagrelor Intermediates
Others
Parecoxib sodium Intermediat…
Canagliflozin Intermediates
Empagliflozin Intermediates
Dapagliflozin Intermediates
Tofacitinib Intermediates
Baricitinib Intermediates
Baricitinib Intermediates
Vonoprazan Fumarate Intermed…
Febuxostat Intermediates
Ceftaroline fosamil Interme…
Rivaroxaban Intermediates
Avatrombopag Intermediates
Ramelteon Intermediates
Pimavanserin Intermediates
Intermediates of Carbapenems…
Dabigatran etexilate Interme…
Crisaborole Intermediates
Finafloxacin Hydrochloride I…
Meropenem
Sacubitril
Apixaban Intermediates
Zolpidem tartrater Intermedi…
Tolvaptan Intermediates
Edoxaban Intermediates
Nucleus and intermediates of…
Acotiamide intermediates
Apremilast intermediates
Roxadustat intermediates
Linagliptin intermediates
Ibrutinib Intermediates
Eltrombopag Intermediates
Posaconazole Intermediates | Name | Ceftaroline intermediate (n-4) |
| Purity | ≥98% |
| Appearance | - |
| Synonym | 7 β - aMino - 3 - [4 - pyridyl - 2 - thiazole sulfur radical ] - 3 - cepheM - 4 - carboxylic acid ·2HCl |
| Cas No. | 400827-70-5 |
| Molecular Formula | C37H31IN4O4S3 |
| Molecular Weight | 818.76591 |
Structural Formula | ![]() |
| Product Introduction | Ceftaroline intermediate (n-4)[400827-70-5] |
| Product Status | Ceftaroline intermediate (n-4)[400827-70-5]Our company has commercialized this product for long-term stable supply. |
| ??Product Quality | For futher detailed of Ceftaroline intermediate (n-4), please download the certification of analysis of 400827-70-5 |
Contact Information | If you are interested in Ceftaroline intermediate (n-4) [400827-70-5],we will provide you with reasonable price, high quality products, looking forward to your contact. |
Copyright Bayeebio Biotech (Shanghai) Co., Ltd. Shanghai 滬ICP備16015574號(hào)
